PharmaCorp Rx Cash Flow Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-1.99	-0.47	-0.52	-0.08
Stock-Based Compensation	0.73	-	0.39	-
Change in Accounts Payable	-0	0.03	-0.01	0.08
Change in Other Net Operating Assets	-0.01	-0.08	0.02	-
Operating Cash Flow	-1.28	-0.52	-0.12	0
Issuance of Common Stock	27.49	0.03	2	3
Other Financing Activities	-	-	-0.13	-0.06
Financing Cash Flow	27.44	0.03	1.87	2.94
Net Cash Flow	24.14	-0.49	1.75	2.94
Free Cash Flow	-1.29	-0.52	-0.12	0
Free Cash Flow Per Share	-0.01	-0.03	-0.01	0.00
Levered Free Cash Flow	-0.72	-0.41	0.04	-
Unlevered Free Cash Flow	-0.71	-0.41	0.04	-
Change in Net Working Capital	0.17	0.05	-0.01	-

Source: S&P Capital IQ. Standard template. Financial Sources.